Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 131Gastrointestinal Stromal Tumors 67Leukemia 66Leukemia, Myeloid, Chronic-Phase 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Blast Crisis 22Brain Neoplasms 15Philadelphia Chromosome 14Melanoma 13Sarcoma 12Neoplasms 12Neoplasm Metastasis 12Leukemia, Myeloid, Acute 12Leukemia, Myeloid, Accelerated Phase 12Glioblastoma 12Lung Neoplasms 11Prostatic Neoplasms 10Leukemia, Myeloid 9Gliosarcoma 9Glioma 8Breast Neoplasms 8Primary Myelofibrosis 7Leukemia, Myelomonocytic, Chronic 7Central Nervous System Neoplasms 7Astrocytoma 7Recurrence 6Polycythemia Vera 6Ovarian Neoplasms 6Oligodendroglioma 6Myeloproliferative Disorders 6

Interventions

Sirolimus 9Everolimus 5Imatinib Mesylate 2temsirolimus 1saracatinib 1nintedanib 1carbon-11 acetate 1Valproic Acid 1Sugars 1Simvastatin 1Resveratrol 1Octreotide 1Loratadine 1Letrozole 1Immunoglobulin G 1Hydroxychloroquine 1Glutamine 1Doxycycline 1Disulfides 1Cetuximab 1Celecoxib 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Lymphangioleiomyomatosis × Imatinib Mesylate × Clear all
NCT06889168 2026-01-21

LAMP-2

Columbia University

Phase 1 Recruiting
20 enrolled

Lymphangioleiomyomatosis

NCT03131999 2020-06-16

LAMP-1

Medical University of South Carolina

Phase 1/2 Completed
18 enrolled 7 charts

Lymphangioleiomyomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡